8-K ·Filed Aug 10, 2026
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral
Monitor the Q2 2026 earnings call on August 10, 2026, for financial results and any commentary on the CEO transition timeline. The stock may see limited volatility from the retirement announcement itself, but the earnings call could provide a clearer catalyst.
Latest settled — T+20d ⚠ clustered
ACH ▼ -21.43% at T+20d
NEUTRAL call -21.43% · α vs SPY -20.51% · entry $1.40 → $1.10
Latest observation: T+46 -67.99% FF3 residual α
T+1d
-10.00%
call -10.00% · α -9.68%
$1.26
settled 3mo ago
T+5d
-23.57%
call -23.57% · α -23.52%
$1.07
settled 2mo ago
T+20d
-21.43%
call -21.43% · α -20.51%
$1.10
settled 7w ago
T+60d
Pending
in 7d
Price Chart
Loading chart...
Executive Summary
Accendra Health CEO Ed Pesicka announced his retirement by end of 2026, with the Board beginning a successor search. The filing is a routine leadership transition with no financial data or guidance provided.
Key Facts
- CEO Edward A. Pesicka notified the Board of his intention to retire by end of 2026 or earlier upon appointment of a successor.
- Pesicka will also retire from the Board of Directors.
- The Board has commenced a process to evaluate and select a successor, leveraging a pre-existing succession planning process.
- Pesicka's retirement is not due to any disagreement with the company regarding operations, policies, or practices.
- Pesicka may serve in an advisory capacity after retirement to ensure a smooth transition.
- The company will host a Q2 2026 earnings conference call on August 10, 2026.
Financial Impact
No financial figures reported in the filing.
Risk Factors
- Succession uncertainty could create a leadership vacuum if a replacement is not named promptly.
- Potential for strategic drift during the transition period.
Market Snapshot
Exchange
NYSE
Sector
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Analyst Consensus
8% bullish (12 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-092973 |
| Document: tm2622667d1_ex99-1.htm | 0001104659-26-092973 |
| Document: 0001104659-26-092973-index-headers.html | 0001104659-26-092973 |
| Document: 0001104659-26-092973-index.html | 0001104659-26-092973 |
| Document: 0001104659-26-092973.txt | 0001104659-26-092973 |
15 reports for ACH
100% Hit rate @ T+5 Went positive at some point 6 of 6 best @ T+60▲ +62.31%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2031 (+47.99%) |
Oct 7, 2026 20d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2031 (−57.05%) |
Sep 17, 2026 5w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2031 (−80.28%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2031 (−83.88%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2031 (+85.49%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2031 (−85.49%) |
Jul 27, 2026 13w ago | EFFECT | $3.22 $3.41 | ▲ +5.90% | ▲ +3.39% | $0.2031 (−93.69%) |
Jun 25, 2026 17w ago | 8-K | $3.34 $3.59 | ▲ +7.49% | ▲ +5.32% | $0.2031 (−93.92%) |
Showing 10 of 15
US Market Status
Market Closed — Opens Wed (15h 31m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers